5-ALA is a compound that also exists naturally in the human body and is involved in the process by which mitochondria produce energy. In clinical studies, trials using 5-ALA together with SFC at doses of up to 200 mg per day in patients with Type 2 diabetes have suggested that there may be relatively few major safety concerns. However, it cannot be said that “because it exists in the body, it has no side effects.” Caution is needed depending on the dose, individual constitution, underlying diseases, and other medications being taken.

People undergoing diabetes treatment should be especially careful about hypoglycemia. If pancreatic function or insulin secretion improves as expected in some research, people using insulin injections or glucose-lowering drugs may experience blood glucose levels that fall too low. The uploaded materials also indicate that, if pancreatic function recovers, insulin management and blood glucose monitoring may become important issues.

For this reason, people with diabetes should not increase the dose of 5-ALA or reduce their medications on their own. They should always consult a physician before taking it.